Quarterly report pursuant to Section 13 or 15(d)

Net Income (Loss) Per Share - Schedule of Antidilutive (Details)

v3.23.1
Net Income (Loss) Per Share - Schedule of Antidilutive (Details) - shares
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Weighted average unvested Time-Based RSUs and Performance-Based RSUs    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 17,531 765
Weighted average stock warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 1,120,000 1,120,000